Carboxymethylcellulose sodium 0.01 MG/MG Ophthalmic Gel — RxCUI 579907
RxNorm drug concept · Semantic clinical drug
RxCUI 579907
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI579907
Official nameCarboxymethylcellulose sodium 0.01 MG/MG Ophthalmic Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascarboxymethylcellulose sodium 1 % Ophthalmic Gel
FDA products mapped6
Package NDCs mapped7
Reported Medicaid activity (SDUD)31,407 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Carboxymethylcellulose sodium 0.01 MG/MG Ophthal... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carboxymethylcellulose sodium 0.01 MG/MG Ophthalmic Gel
RxCUI 579907 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Carboxymethylcellulose
2062IN -
Carboxymethylcellulose sodium
491498PIN
-
Carboxymethylcellulose
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
TheraTears
220262BN
-
TheraTears
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carboxymethylcellulose Ophthalmic Gel
376464SCDF -
Carboxymethylcellulose sodium Ophthalmic Gel
2645459SCDFP -
Carboxymethylcellulose Ophthalmic Product
1151388SCDG -
Carboxymethylcellulose sodium Ophthalmic Product
2661596SCDGP -
Carboxymethylcellulose Ophthalmic Gel [TheraTears]
998665SBDF -
Carboxymethylcellulose sodium Ophthalmic Gel [TheraTears]
2654542SBDFP -
TheraTears Ophthalmic Product
1186113SBDG -
Ophthalmic Gel
316963DF - +1 more in this family
-
Carboxymethylcellulose Ophthalmic Gel
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carboxymethylcellulose sodium 0.01 MG/MG
1374724SCDC -
Carboxymethylcellulose sodium 0.01 MG/MG Ophthalmic Gel [TheraTears]
998666SBD -
Carboxymethylcellulose sodium 0.01 MG/MG [TheraTears]
2532167SBDC
-
Carboxymethylcellulose sodium 0.01 MG/MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carboxymethylcellulose sodium 0.01 MG/MG
SCDC · 1374724 -
Carboxymethylcellulose Ophthalmic Gel
SCDF · 376464 -
Carboxymethylcellulose sodium Ophthalmic Gel
SCDFP · 2645459 -
Carboxymethylcellulose Ophthalmic Product
SCDG · 1151388 -
Carboxymethylcellulose sodium Ophthalmic Product
SCDGP · 2661596
Brand-Name Concepts
-
Carboxymethylcellulose sodium 0.01 MG/MG Ophthalmic Gel [TheraTears]
SBD · 998666 -
Carboxymethylcellulose sodium 0.01 MG/MG [TheraTears]
SBDC · 2532167 -
Carboxymethylcellulose Ophthalmic Gel [TheraTears]
SBDF · 998665 -
Carboxymethylcellulose sodium Ophthalmic Gel [TheraTears]
SBDFP · 2654542 -
TheraTears Ophthalmic Product
SBDG · 1186113 -
TheraTears
BN · 220262
📦 FDA Products & Package NDCs
6 products · 7 package NDCs
7 package NDCs map to RxCUI 579907 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00023-4554-05 | 5 VIAL, SINGLE-USE in 1 CARTON (0023-4554-05) / .4 mL in 1... | REFRESH CELLUVISC | Allergan, Inc. | 1989-10-04 |
| 00023-4554-30 | 30 VIAL, SINGLE-USE in 1 CARTON (0023-4554-30) / .4 mL in 1... | REFRESH CELLUVISC | Allergan, Inc. | 1989-10-04 |
| 00023-9205-15 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9205-15) / 15 mL in 1 B... | REFRESH LIQUIGEL | Allergan, Inc. | 2001-10-04 |
| 50268-0065-30 | 30 VIAL, SINGLE-USE in 1 CARTON (50268-065-30) / .4 mL in 1... | carboxymethylcellulose sodium | AvPAK | 2020-11-18 |
| 58790-0002-28 | 7 POUCH in 1 CARTON (58790-002-28) / .6 mL in 1 POUCH | TheraTears | MEDTECH PRODUCTS INC | 2002-12-01 |
| 58790-0003-30 | 6 POUCH in 1 CARTON (58790-003-30) / 5 VIAL in 1 POUCH / .6... | TheraTears | MEDTECH PRODUCTS INC | 2018-12-07 |
| 70000-0089-01 | 1 BOTTLE, DROPPER in 1 CARTON (70000-0089-1) / 15 mL in 1 B... | Dry Eye Relief | CARDINAL HEALTH 110, LLC. DBA LEADER | 2021-03-09 |
Observed labelers:
Allergan, Inc. (3) ·
MEDTECH PRODUCTS INC (2) ·
AvPAK (1) ·
CARDINAL HEALTH 110, LLC. DBA LEADER (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.